{
    "clinical_study": {
        "@rank": "83819", 
        "arm_group": [
            {
                "arm_group_label": "GFT505 80mg", 
                "arm_group_type": "Experimental", 
                "description": "Hard gelatin capsules dosed at 40mg, oral administration, 3 capsules per day before breakfast with a glass of water."
            }, 
            {
                "arm_group_label": "GFT505 120mg", 
                "arm_group_type": "Experimental", 
                "description": "Hard gelatin capsules dosed at 40mg, oral administration, 3 capsules per day before breakfast with a glass of water."
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "hard gelatin capsules, oral administration, 3 capsules per day before breakfast with a glass of water."
            }
        ], 
        "brief_summary": {
            "textblock": "Abdominal obesity and type-2 Diabetes are associated with chronic liver disorders resulting\n      from the accumulation of fat in the liver (steatosis), which may progress towards hepatitis\n      and possibly lead to cirrhosis and liver cancer. NAFLD (Non Alcoholic Fatty Liver Disease)\n      is considered as the most common form of chronic liver disease in adults in the United\n      States, Australia, Asia and Europe. In the USA, the estimated prevalence of NAFLD is 20-30%\n      of the adult population.\n\n      Non-alcoholic Steatohepatitis (NASH) is a progressing form of NAFLD, which corresponds to\n      hepatic steatosis associated with inflammation and liver cell injury upon microscopic\n      examination of a liver biopsy. This condition may lead to advanced fibrosis and cirrhosis\n      and deserves serious medical management. Up to now, there is no effective drug which has\n      clearly demonstrated therapeutic efficacy which may help lifestyle and dietary\n      recommendations in the resolution of NASH.\n\n      In this context, GENFIT is developing a new liver targeted drug candidate, GFT505, for the\n      treatment of NASH and the reduction of multiple cardiometabolic risk factors associated with\n      the metabolic syndrome and type 2 Diabetes.\n\n      This phase IIb study will evaluate the efficacy and safety of GFT505 80mg and 120mg once\n      daily for 52 weeks on the reversal of NASH without worsening of fibrosis, based on liver\n      biopsy assessments."
        }, 
        "brief_title": "Phase IIb Study to Evaluate the Efficacy and Safety of GFT505 Versus Placebo in Patients With Non-Alcoholic Steatohepatitis (NASH)", 
        "completion_date": {
            "#text": "March 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Non-Alcoholic Steatohepatitis (NASH)", 
        "condition_browse": {
            "mesh_term": "Fatty Liver"
        }, 
        "detailed_description": {
            "textblock": "The study duration per patient will be 80 weeks. A screening period (from 4 to 16 weeks)\n      will precede a 52-week double-blind treatment period and a 3 months follow-up period.\n\n      The study will be conducted in 270 patients (90 patients in the placebo arm, 90 patients in\n      the GFT505 80mg arm, and 90 patients in the GFT505 120mg arm).\n\n      Enrollment will be performed in two phases: during the first phase, the patients will\n      receive either GFT505 at a dose of 80 mg either the placebo. An independent expert committee\n      will review the safety data when 45 patients receiving the dose at 80 mg will have been\n      treated for 6 months. The committee approval will be necessary to start the second phase,\n      while the patients will receive either GFT505 at a dose of 80 mg, or GFT505 at a dose of 120\n      mg or the placebo."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Males or females (females must be either of non-child bearing potential or using an\n             efficient double contraception). For male participants, contraceptive measures must\n             be taken during the study, either by the male participant or his female partner.\n\n          -  Body Mass Index \u2264 45 kg/m\u00b2.\n\n          -  Patients agree to have one liver biopsy during the screening period for diagnostic\n             purpose (if no historical biopsy within 6 months before randomization is available)\n             and one at the end of the treatment period for assessment of the treatment effects.\n\n          -  For hypertensive patients, hypertension must be controlled by stable dose of\n             anti-hypertensive medication for at least 2 months prior to screening (and the stable\n             dose can be maintained throughout the study).\n\n          -  Patients treated with vitamin E (>400IU/d), or Polyunsaturated fatty acids\n             (>2g/day)or Ursodeoxycholic acid can be included if drugs are stopped at least 3\n             months prior to diagnostic liver biopsy and up to the end of the study.\n\n          -  Histological confirmation of steatohepatitis on a diagnostic liver biopsy.\n             Histological diagnostic is confirmed by central reading of the slides (steatosis > 5%\n             + lobular inflammation, any grade + ballooning, any amount).\n\n          -  For patients with Type 2 Diabetes, glycemia must be controlled (Glycosylated\n             Haemoglobin A1c \u22648.5%). If glycemia is controlled by anti-diabetic drugs, qualitative\n             change is not permitted within 6 months prior to randomization and should be avoided\n             during the study. Treatments with metformin, Dipeptidyl Peptidase 4 inhibitors,\n             Glucagon-like peptide-1 agonists, sulfamides, insulin are authorized. Sulfamides and\n             insulin are permitted if glycemia is self-monitored by the patient.\n\n        Exclusion Criteria:\n\n          -  Known heart failure (Grade I to IV of New York Heart Association classification).\n\n          -  Weight loss of more than 5% within 6 months prior to randomization.\n\n          -  History of bariatric surgery.\n\n          -  Uncontrolled Blood Pressure.\n\n          -  Type 1 diabetes patients.\n\n          -  Patients who had an acute cardiovascular episode within the 6 months prior to\n             screening, or with a history of coronary angioplasty, history of stroke, Transient\n             Ischemic Attack, Coronary Heart Disease.\n\n          -  Compensated and uncompensated cirrhosis. Notably, NASH patients with fibrosis stage =\n             4 according to the NASH CRN fibrosis staging system are excluded.\n\n          -  Known alcohol and/or any other drug abuse or dependence in the last five years.\n\n          -  Pregnant or lactating females.\n\n          -  Other well documented causes of chronic liver disease\n\n          -  Known intolerance or contra-indication to the list of excipients of GFT505.\n\n          -  Evidence of any other unstable or, untreated clinically significant immunological,\n             neoplastic, endocrine, haematological, gastrointestinal, neurological or psychiatric\n             disorder.\n\n          -  Positive HBsAg (Hepatitis B Surface Antigen), Positive anti-HIV, positive HCV-RNA\n             (Hepatitis C Virus).\n\n          -  Uncontrolled hypothyroidism defined as Thyroid Stimulating Hormone > 2X the upper\n             limit of normal (ULN). Thyroid dysfunction controlled for at least 6 months prior to\n             screening is permitted.\n\n          -  Significant renal disease, including nephritic syndrome, chronic renal failure\n             (defined as creatinine clearance < 60 mL/mn and serum creatinine >180 \u03bcmol/L).\n\n          -  Unexplained serum creatine phosphokinase (CPK) > 3X the upper limit of normal (ULN).\n             Patients with a reason for CPK elevation may have the measurement repeated prior to\n             randomization; a CPK retest > 3X ULN leads to exclusion."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "270", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 24, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01694849", 
            "org_study_id": "GFT505-212-7", 
            "secondary_id": "2012-000295-42"
        }, 
        "intervention": [
            {
                "arm_group_label": "GFT505 80mg", 
                "intervention_name": "GFT505 80mg", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "GFT505 120mg", 
                "intervention_name": "GFT505 120mg", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "PPARs", 
            "NASH", 
            "Non-Alcoholic Steatohepatitis", 
            "Liver Diseases", 
            "Fibrosis"
        ], 
        "lastchanged_date": "February 25, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Fresno", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "CA 9372"
                    }, 
                    "name": "Site 920"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "La Jolla", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "CA 92037"
                    }, 
                    "name": "Site 903"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Aurora", 
                        "country": "United States", 
                        "state": "Colorado", 
                        "zip": "CO 80045"
                    }, 
                    "name": "Site 911"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Gainesville", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "FL 32610-0277"
                    }, 
                    "name": "Site 912"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Miami", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "FL 33136"
                    }, 
                    "name": "Site 915"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Atlanta", 
                        "country": "United States", 
                        "state": "Georgia", 
                        "zip": "GA 30322"
                    }, 
                    "name": "Site 917"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Atlanta", 
                        "country": "United States", 
                        "state": "Georgia", 
                        "zip": "GA 30303"
                    }, 
                    "name": "Site 924"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Indianapolis", 
                        "country": "United States", 
                        "state": "Indiana", 
                        "zip": "IN 46202"
                    }, 
                    "name": "Site 910"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lexington", 
                        "country": "United States", 
                        "state": "Kentucky", 
                        "zip": "KY 40536"
                    }, 
                    "name": "Site 904"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New Orleans", 
                        "country": "United States", 
                        "state": "Louisiana", 
                        "zip": "LA 70112-2600"
                    }, 
                    "name": "Site 909"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Worcester", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "MA 01655"
                    }, 
                    "name": "Site 921"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Detroit", 
                        "country": "United States", 
                        "state": "Michigan", 
                        "zip": "MI 48202"
                    }, 
                    "name": "Site 902"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "St. Louis", 
                        "country": "United States", 
                        "state": "Missouri", 
                        "zip": "MO 63110"
                    }, 
                    "name": "Site 922"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "NY 10029-6574"
                    }, 
                    "name": "Site 927"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Durham", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "NC 27710"
                    }, 
                    "name": "Site 908"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Philadelphia", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "PA 19104"
                    }, 
                    "name": "Site 919"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Providence", 
                        "country": "United States", 
                        "state": "Rhode Island", 
                        "zip": "RI 02903"
                    }, 
                    "name": "Site 918"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Charleston", 
                        "country": "United States", 
                        "state": "South Carolina", 
                        "zip": "SC 29425"
                    }, 
                    "name": "Site 925"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Memphis", 
                        "country": "United States", 
                        "state": "Tennessee", 
                        "zip": "TN 38104"
                    }, 
                    "name": "Site 916"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Fort Sam Houston", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "TX 78234"
                    }, 
                    "name": "Site 913"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "TX 77030"
                    }, 
                    "name": "Site 923"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Antonio", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "TX 78215"
                    }, 
                    "name": "Site 906"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Salt Lake City", 
                        "country": "United States", 
                        "state": "Utah", 
                        "zip": "UT 84132"
                    }, 
                    "name": "Site 931"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Charlottesville", 
                        "country": "United States", 
                        "state": "Virginia", 
                        "zip": "VA 22908"
                    }, 
                    "name": "Site 930"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Richmond", 
                        "country": "United States", 
                        "state": "Virginia", 
                        "zip": "VA 23298"
                    }, 
                    "name": "Site 901"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Brussels", 
                        "country": "Belgium", 
                        "zip": "1070"
                    }, 
                    "name": "Site 205"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Edegem", 
                        "country": "Belgium", 
                        "zip": "B-2650"
                    }, 
                    "name": "Site 201"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Gent", 
                        "country": "Belgium", 
                        "zip": "B-9000"
                    }, 
                    "name": "Site 204"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Haine-Saint-Paul", 
                        "country": "Belgium", 
                        "zip": "7100"
                    }, 
                    "name": "Site 202"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Leuven", 
                        "country": "Belgium", 
                        "zip": "3000"
                    }, 
                    "name": "Site 203"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Amiens", 
                        "country": "France", 
                        "zip": "80054"
                    }, 
                    "name": "Site 106"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Angers", 
                        "country": "France", 
                        "zip": "49933"
                    }, 
                    "name": "Site 102"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Clichy", 
                        "country": "France", 
                        "zip": "92110"
                    }, 
                    "name": "Site 114"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lille", 
                        "country": "France", 
                        "zip": "59037"
                    }, 
                    "name": "Site 103"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lyon", 
                        "country": "France", 
                        "zip": "69317"
                    }, 
                    "name": "Site 113"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Marseille", 
                        "country": "France", 
                        "zip": "13285"
                    }, 
                    "name": "Site 111"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Montpellier", 
                        "country": "France", 
                        "zip": "34295"
                    }, 
                    "name": "Site 108"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nantes", 
                        "country": "France", 
                        "zip": "44093"
                    }, 
                    "name": "Site 104"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nice", 
                        "country": "France", 
                        "zip": "06202"
                    }, 
                    "name": "Site 109"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France", 
                        "zip": "75571"
                    }, 
                    "name": "Site 112"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France", 
                        "zip": "75651"
                    }, 
                    "name": "Site 101"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pessac", 
                        "country": "France", 
                        "zip": "33604"
                    }, 
                    "name": "Site 107"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bochum", 
                        "country": "Germany", 
                        "zip": "44791"
                    }, 
                    "name": "Site 403"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bonn", 
                        "country": "Germany", 
                        "zip": "53127"
                    }, 
                    "name": "Site 405"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hannover", 
                        "country": "Germany", 
                        "zip": "30625"
                    }, 
                    "name": "Site 401"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Mainz", 
                        "country": "Germany", 
                        "zip": "55131"
                    }, 
                    "name": "Site 404"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "T\u00fcbingen", 
                        "country": "Germany", 
                        "zip": "72076"
                    }, 
                    "name": "Site 402"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bologna", 
                        "country": "Italy", 
                        "zip": "40138"
                    }, 
                    "name": "Site 506"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bologna", 
                        "country": "Italy", 
                        "zip": "40138"
                    }, 
                    "name": "Site 505"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Milano", 
                        "country": "Italy", 
                        "zip": "20122"
                    }, 
                    "name": "Site 507"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Palermo", 
                        "country": "Italy", 
                        "zip": "90127"
                    }, 
                    "name": "Site 503"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Roma", 
                        "country": "Italy", 
                        "zip": "00133"
                    }, 
                    "name": "Site 504"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Torino", 
                        "country": "Italy", 
                        "zip": "10126"
                    }, 
                    "name": "Site 501"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Amsterdam", 
                        "country": "Netherlands", 
                        "zip": "1100"
                    }, 
                    "name": "Site 303"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nijmegen", 
                        "country": "Netherlands", 
                        "zip": "6500"
                    }, 
                    "name": "Site 302"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bucharest", 
                        "country": "Romania", 
                        "zip": "022328"
                    }, 
                    "name": "Site 601"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bucharest", 
                        "country": "Romania", 
                        "zip": "022328"
                    }, 
                    "name": "Site 602"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bucharest", 
                        "country": "Romania", 
                        "zip": "021105"
                    }, 
                    "name": "Site 603"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Alcorc\u00f3n", 
                        "country": "Spain", 
                        "zip": "28922"
                    }, 
                    "name": "Site 704"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Aranjuez", 
                        "country": "Spain", 
                        "zip": "28300"
                    }, 
                    "name": "Site 702"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Barcelona", 
                        "country": "Spain", 
                        "zip": "08036"
                    }, 
                    "name": "Site 703"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Majadahonda", 
                        "country": "Spain", 
                        "zip": "28222"
                    }, 
                    "name": "Site 707"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Malaga", 
                        "country": "Spain", 
                        "zip": "29010"
                    }, 
                    "name": "Site 705"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pontevedra", 
                        "country": "Spain", 
                        "zip": "36071"
                    }, 
                    "name": "Site 709"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Santander", 
                        "country": "Spain", 
                        "zip": "39008"
                    }, 
                    "name": "Site 706"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sevilla", 
                        "country": "Spain", 
                        "zip": "41014"
                    }, 
                    "name": "Site 701"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Birmingham", 
                        "country": "United Kingdom", 
                        "zip": "B15 2TT"
                    }, 
                    "name": "Site 804"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Camberley", 
                        "country": "United Kingdom", 
                        "zip": "GU16 7UJ"
                    }, 
                    "name": "Site 802"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cambridge", 
                        "country": "United Kingdom", 
                        "zip": "CB2 0QQ"
                    }, 
                    "name": "Site 809"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hull", 
                        "country": "United Kingdom", 
                        "zip": "HU3 2JZ"
                    }, 
                    "name": "Site 808"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "London", 
                        "country": "United Kingdom", 
                        "zip": "W2 1NY"
                    }, 
                    "name": "Site 807"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Newcastle Upon Tyne", 
                        "country": "United Kingdom", 
                        "zip": "NE7 7DN"
                    }, 
                    "name": "Site 801"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nottingham", 
                        "country": "United Kingdom", 
                        "zip": "NG7 2UH"
                    }, 
                    "name": "Site 803"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sheffield", 
                        "country": "United Kingdom", 
                        "zip": "S10 2JF"
                    }, 
                    "name": "Site 810"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Belgium", 
                "France", 
                "Germany", 
                "Italy", 
                "Netherlands", 
                "Romania", 
                "Spain", 
                "United Kingdom"
            ]
        }, 
        "number_of_arms": "3", 
        "official_title": "A Multicentre, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GFT505 Once Daily on Steatohepatitis in Patients With Non-Alcoholic Steatohepatitis (NASH).", 
        "overall_official": [
            {
                "affiliation": "Development Director Genfit, France", 
                "last_name": "R\u00e9my HANF, PhD", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "International Coordinator - La Piti\u00e9-Salp\u00eatri\u00e8re Hospital - Paris 13, France", 
                "last_name": "Pr. Vlad RATZIU, M.D.", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "National Coordinator -Virginia Commonwealth University - Richmond - USA", 
                "last_name": "Pr. Arun SANYAL, M.D.", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "National Coordinator - UZA - Edegem - Belgium", 
                "last_name": "Dr. Sven FRANCQUE, M.D.", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "National Coordinator - UMC St Radboud Nijmegen - Nijmegen - The Netherlands", 
                "last_name": "Dr. Jost PH DRENTH, MD, Ph.D", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "National Coordinator - Medical School of Hannover - Hannover - Germany", 
                "last_name": "Pr. Michael Manns, M.D.", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "National Coordinator - University of Torino - S. Giovanni Battista Hospital - Torino - Italy", 
                "last_name": "Pr. Elisabetha BUGIANESI, M.D.", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "National Coordinator - Center of Internal Medicine, Fundeni Clinical Institute - Bucharest - Romania", 
                "last_name": "Pr. Mihai VOICULESCU, M.D.", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "National Coordinator - Valme University hospital - Sevilla - Spain", 
                "last_name": "Pr. Manuel ROMERO-GOMEZ, M.D.", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "National Coordinator - Freeman Hospital - Newcastle - UK", 
                "last_name": "Pr. Quentin M. ANSTEE, M.D.", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": [
                "United States: Food and Drug Administration", 
                "Belgium: Federal Agency for Medicinal Products and Health Products", 
                "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9", 
                "Germany: Federal Institute for Drugs and Medical Devices", 
                "Italy: The Italian Medicines Agency", 
                "Romania: National Agency for Medicines and Medical Devices", 
                "Spain: Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios", 
                "Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)", 
                "United Kingdom: Medicines and Healthcare Products Regulatory Agency"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "To evaluate after 52 weeks of daily administration of GFT505 80mg, or GFT505 120mg, the percentage of responders from baseline to Week 52, defined by the disappearance of steatohepatitis (i.e. patients no longer meeting the criteria for steatohepatitis) without worsening of fibrosis.\nWorsening of fibrosis is evaluated using NASH CRN (Clinical Research Network) fibrosis staging system and defined as:\nProgression to stage 3 or 4 for patients at stage 0, 1 or 2 on diagnostic liver biopsy\nProgression to stage 4 for patients at stage 3 on diagnostic liver biopsy", 
            "measure": "Percentage of responders defined by the disappearance of steatohepatitis without worsening of fibrosis", 
            "safety_issue": "Yes", 
            "time_frame": "52 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01694849"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "To evaluate after 52 weeks of daily administration of GFT505 80mg, or GFT505 120mg, the percentage of responders from baseline to week 52, defined by the disappearance of steatohepatitis (i.e. patients no longer meeting the criteria for steatohepatitis).", 
                "measure": "Percentage of responders, defined by the disappearance of steatohepatitis", 
                "safety_issue": "Yes", 
                "time_frame": "52 weeks"
            }, 
            {
                "description": "To evaluate after 52 weeks of daily administration of GFT505 80mg, or GFT505 120mg, the change from baseline to week 52, in NAS score (Non-alcoholic fatty liver disease Activity Score).", 
                "measure": "NAS score (Non-alcoholic fatty liver disease Activity Score)", 
                "safety_issue": "Yes", 
                "time_frame": "52 weeks"
            }, 
            {
                "description": "To evaluate after 52 weeks of daily administration of GFT505 80mg, or GFT505 120mg, the changes from baseline to week 52, in stages of steatosis, hepatic activity (lobular inflammation + ballooning).", 
                "measure": "Stages of steatosis, hepatic activity", 
                "safety_issue": "Yes", 
                "time_frame": "52 weeks"
            }, 
            {
                "description": "To evaluate after 52 weeks of daily administration of GFT505 80mg, or GFT505 120mg, the changes from baseline to Week 52, in stages of fibrosis (NASH CRN scoring = Non-Alcoholic Steatohepatitis Clinical Research Network scoring).", 
                "measure": "Stages of fibrosis", 
                "safety_issue": "Yes", 
                "time_frame": "52 weeks"
            }, 
            {
                "description": "To evaluate after 52 weeks of daily administration of GFT505 80mg, or GFT505 120mg, the changes from baseline to Week 52, in area of fibrosis by morphometry", 
                "measure": "Area of fibrosis", 
                "safety_issue": "Yes", 
                "time_frame": "52 weeks"
            }, 
            {
                "description": "To evaluate after 52 weeks of daily administration of GFT505 80mg, or GFT505 120mg, the changes from baseline to week 52, in liver enzymes.", 
                "measure": "Liver enzymes", 
                "safety_issue": "Yes", 
                "time_frame": "52 weeks"
            }, 
            {
                "description": "To evaluate after 52 weeks of daily administration of GFT505 80mg, or GFT505 120mg, the changes from baseline to week 52, in non-invasive markers of fibrosis and steatosis.", 
                "measure": "Non-invasive markers of fibrosis and steatosis", 
                "safety_issue": "Yes", 
                "time_frame": "52 weeks"
            }, 
            {
                "description": "To evaluate after 52 weeks of daily administration of GFT505 80mg, or GFT505 120mg, the changes from baseline to week 52, in lipid parameters.", 
                "measure": "Lipid parameters", 
                "safety_issue": "Yes", 
                "time_frame": "52 weeks"
            }, 
            {
                "description": "To evaluate after 52 weeks of daily administration of GFT505 80mg, or GFT505 120mg, the changes from baseline to week 52, in body weight.", 
                "measure": "Body weight", 
                "safety_issue": "Yes", 
                "time_frame": "52 weeks"
            }, 
            {
                "description": "To evaluate after 52 weeks of daily administration of GFT505 80mg, or GFT505 120mg, the changes from baseline to week 52, in insulin resistance.", 
                "measure": "Insulin resistance", 
                "safety_issue": "Yes", 
                "time_frame": "52 weeks"
            }, 
            {
                "description": "To evaluate after 52 weeks of daily administration of GFT505 80mg, or GFT505 120mg, the changes from baseline to week 52, in inflammatory markers.", 
                "measure": "Inflammatory markers", 
                "safety_issue": "Yes", 
                "time_frame": "52 weeks"
            }, 
            {
                "description": "To evaluate after 52 weeks of daily administration of GFT505 80mg, or GFT505 120mg, the changes from baseline to week 52, in safety markers (renal or cardiac function parameters).", 
                "measure": "Safety markers", 
                "safety_issue": "Yes", 
                "time_frame": "52 weeks"
            }, 
            {
                "description": "To evaluate after 52 weeks of daily administration of GFT505 80mg, or GFT505 120mg, the changes from baseline to week 52, in cardiovascular risk profile.", 
                "measure": "Cardiovascular risk profile", 
                "safety_issue": "Yes", 
                "time_frame": "52 weeks"
            }
        ], 
        "source": "Genfit", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "NATURALPHA", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "PREMIER RESEARCH GROUP", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Genfit", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "September 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}